Cargando…

Infliximab as a rescue therapy in the management of refractory typical infantile Kawasaki disease

Detalles Bibliográficos
Autores principales:	Venkatnarayanan, K., Arora, Harmeet S., Gupta, Aparajita, Adhikari, K.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127213/ https://www.ncbi.nlm.nih.gov/pubmed/32292233 http://dx.doi.org/10.1016/j.mjafi.2018.06.007

Ejemplares similares

Infliximab as rescue therapy in refractory Kawasaki disease
por: Rodríguez-González, Moisés, et al.
Publicado: (2014)

Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
por: Song, Min Seob, et al.
Publicado: (2010)

Infliximab as an alternative therapy for refractory adult onset Kawasaki disease: A case report
por: Kawaguchi, Takeshi, et al.
Publicado: (2018)

Typical Kawasaki disease
por: Marchesi, Alessandra, et al.
Publicado: (2015)

Dramatic response to infliximab in refractory neurosarcoidosis
por: Chintamaneni, Sreekanth, et al.
Publicado: (2010)

Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation
por: Chang, Victoria A., et al.
Publicado: (2018)

Vedolizumab Attenuates Immune-Checkpoint-Therapy-Induced Infliximab-Refractory Colitis
por: Kaneoka, Ayaka, et al.
Publicado: (2022)

Stellate Ganglion Block as Rescue Therapy in Refractory Ventricular Tachycardia
por: Rajesh, M. C., et al.
Publicado: (2017)

Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report
por: Dang, Harry, et al.
Publicado: (2020)

Unusual imaging presentation of infantile atypical Kawasaki disease
por: Kumar, Nishith, et al.
Publicado: (2016)

A Case of Peritoneal Tuberculosis Developed after Infliximab Therapy for Refractory RA
por: Min, Ji-Yeon, et al.
Publicado: (2012)

Refractory Kawasaki disease: diagnostic and management challenges
por: Duignan, Sophie, et al.
Publicado: (2019)

Inﬂiximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis
por: Miyata, Koichi, et al.
Publicado: (2023)

Infliximab for Idiopathic Deep Cutaneous Vasculitis Refractory to Cyclophosphamide
por: Schafranski, Marcelo Derbli, et al.
Publicado: (2010)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab
por: Matsuo, Satoko, et al.
Publicado: (2017)

Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
por: Eun, Lucy Youngmin
Publicado: (2019)

Cyclosporine for refractory Kawasaki disease with psoriasiform eruption
por: Leyendecker, Mara, et al.
Publicado: (2021)

Infliximab for the treatment of refractory scleritis
por: Doctor, Priyanka, et al.
Publicado: (2009)

Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report
por: Li, Yue, et al.
Publicado: (2013)

Significance of Differential Characteristics in Infantile Kawasaki Disease
por: Kwak, Ji Hee, et al.
Publicado: (2019)

Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent
por: Yeates, Jessica, et al.
Publicado: (2010)

Remission of Refractory Celiac Disease With Infliximab in a Pediatric Patient
por: Rawal, Nidhi, et al.
Publicado: (2015)

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
por: Salehzadeh, Farhad, et al.
Publicado: (2019)

The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis
por: Li, Dan, et al.
Publicado: (2021)

Infliximab Treatment of Refractory Cardiac Sarcoidosis
por: Asawaeer, Majid, et al.
Publicado: (2020)

Recurrent refractory Kawasaki disease
por: Costa Reis, P, et al.
Publicado: (2011)

Clinical observations on infliximab treatment of infantile onset Takayasu arteritis
por: Kang, Min, et al.
Publicado: (2022)

Erratum: Significance of Differential Characteristics in Infantile Kawasaki Disease
por: Kwak, Ji Hee, et al.
Publicado: (2020)

Refractory constrictive pericarditis caused by an immune checkpoint inhibitor properly managed with infliximab: a case report
por: Moriyama, Shohei, et al.
Publicado: (2021)

Peripheral Gangerene, an Unusual Presentation of Infantile Kawasaki: A Case Report and Literature Review
por: Tahghighi, Fatemeh, et al.
Publicado: (2021)

Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report
por: Brogan, Robert J, et al.
Publicado: (2009)

Rheumatoid Arthritis: Refractory to Infliximab, a Tumor Necrosis Factor Inhibitor
por: Solehan, Hana Maizuliana bt, et al.
Publicado: (2011)

A Case Series of Refractory Cutaneous Sarcoidosis Successfully Treated with Infliximab
por: Tuchinda, Papapit, et al.
Publicado: (2012)

Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease
por: Nakamura, Akihiro, et al.
Publicado: (2016)

A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
por: Poushanchi, Behdod, et al.
Publicado: (2018)

Recurrent and refractory corneal perforation secondary to rheumatoid arthritis treated with infliximab
por: Al Saleh, Ahmed, et al.
Publicado: (2021)

Infliximab for Steroid-Refractory Immune Checkpoint Inhibitor-Induced Acute Pancreatitis
por: Townsend, Matthew J., et al.
Publicado: (2023)

Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn’s disease during infliximab therapy
por: Numakura, Tadahisa, et al.
Publicado: (2016)

Efficacy of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis
por: Lu, Zhongxing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_htotb6sroj811ta9jnjr4ti9fd